~~<i id='5547A0B1B1'><strike id='5547A0B1B1'><tt id='5547A0B1B1'><pre id='5547A0B1B1'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：entertainment 2025-09-27 17:06:57 Page View：86578

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bursting ice dam in Alaska highlights risks of glacial flooding around the globe
Next article： Duchenne breakthrough therapy leaves behind pioneering families

comprehensive

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

'Ancient DNA,' 23andMe reveal African American ancestries

TheIsabellafurnacestackatCatoctinFurnace,nearFrederick,Md.CourtesyCamMillerNewresearchthatcombineste

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Gilgo Beach: Police identify another victim in serial killing investigation

9:19KarenVergatainaphotoSuffolkCountypolicedisplayedatapressconference,Aug.4,2023,toannouncethatGilg